FICO reports its Q2 fiscal 2026 results today after the market close, arriving at a complicated moment — the stock trades at $1,013.83, down 40% year-to-date, while the analyst consensus still carries an implied upside of over 60%.
Options positioning into today's print is slightly more defensive than normal, though not extreme. The put/call ratio moved up to 0.68, nearly two standard deviations above its 20-day average of 0.61. That makes it a mildly elevated hedge, not a panic read — and well below FICO's own 52-week PCR high of 1.75. Short sellers have become modestly more active: SI % of free float climbed to 6.1%, up around 9% over the past month, with most of that increase front-loaded into the final few days before earnings. Utilization is at 5.75%, down from its April peak of 7.2%, suggesting the short base is real but not under pressure. Borrowing costs remain negligible at 0.43% — not a stock where anyone is paying a premium to be short.
The bull and bear debate pulls in sharply different directions. Bulls point to FICO's Scores segment, where year-over-year revenue growth topped 29% last quarter on strong mortgage and auto demand, and where recurring price increases on the FICO Score itself provide an unusually durable revenue lever. Bears focus on the software side, where non-platform annual recurring revenue slipped 7.6% year-over-year, and where the ability to scale to consensus growth and margin estimates remains unproven. Analyst targets have moved in one direction only since the start of the year: down, and sharply. Goldman Sachs cut its target to $1,528 from $1,770 in early April, maintaining Buy. Barclays trimmed to $1,950 from $2,400 while staying Overweight. Wells Fargo made the most aggressive revision on April 23rd, slashing its target to $1,650 from $2,300. The mean consensus target of $1,641 is a genuine data point — it represents more than 60% upside from the current price — but that gap reflects a target base set before the stock's 40% YTD drawdown, and the direction of travel is clearly toward compression. The RSI14 at 41.7 confirms the stock is in technically weak territory without being oversold.
Ownership flows offer one additional nuance. Capital Research added nearly 395,000 shares in the most recent filing period, lifting its stake to 6.7% of shares outstanding — the largest institutional position change among top holders. Against that, CEO William Lansing reported a reduction of 21,491 shares in early January, and two independent directors sold modest amounts in February at prices between $1,228 and $1,360, both well above where the stock trades today.
Today's print is ultimately a test of whether FICO's Scores business can sustain the revenue growth rate that underpins analyst targets, and whether the software segment can show any trajectory that narrows the gap between the current multiple and the premium the Street is still willing to assign it.
See the live data behind this article on ORTEX.
Open FICO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
